Trump takes action to re-shore production of essential medicines

7 August 2020
donald_trump_politics_large

US President Donald Trump on Thursday signed an Executive Order to increase American production of essential medical supplies and cut down the nation’s reliance on foreign producers of medicines.

Peter Navarro, director of the White House's Office of Trade and Manufacturing Policy, said on a press call Thursday that the COVID-19 pandemic had made clear the need for the executive order, another in a long line of "Buy American" and "Hire American” directives introduced during the Trump administration.

Under the order, the Commissioner of Food and Drugs is directed to create a list of medicines, medical countermeasures, and critical inputs that are essential for public health in America.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics